Online citations, reference lists, and bibliographies.
← Back to Search

The S-LANSS Score For Identifying Pain Of Predominantly Neuropathic Origin: Validation For Use In Clinical And Postal Research.

M. Bennett, B. Smith, N. Torrance, J. Potter
Published 2005 · Medicine
Referenced 1 time by Citationsy Users

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This article describes the development and validation of the S-LANSS score, a self-report version of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale. The S-LANSS aims to identify pain of predominantly neuropathic origin, as distinct from nociceptive pain, without the need for clinical examination. Two hundred patients with chronic pain were asked to complete the S-LANSS unaided. A researcher then administered the S-LANSS scale and the Neuropathic Pain Scale (NPS) in interview format. An independent clinician determined the pain type (neuropathic versus nociceptive) and rated his or her certainty about diagnosis. The S-LANSS scale was also incorporated into a chronic pain questionnaire that was sent to 160 community patients and 150 newly referred patients waiting for pain clinic assessment. The S-LANSS scale correctly identified 75% of pain types when self-completed and 80% when used in interview format. Sensitivity for self-completed S-LANSS scores ranged from 74% to 78%, depending on the cutoff score. There were significant associations between NPS items and total score with S-LANSS score. In the postal survey, completed questionnaires were returned by 57% of patients (n = 174). Internal consistency and convergent validity of the survey S-LANSS scores were confirmed. The findings support the S-LANSS scale as a valid and reliable self-report instrument for identifying neuropathic pain and it is also acceptable for use in postal survey research. Establishing valid measures of symptoms and signs in neuropathic pain will allow standardized comparisons with other investigational measures. This might lead to new insights into the relationship between pathophysiologic mechanisms and clinical manifestations of pain.
This paper references
10.1097/00002508-200209000-00004
The Lidocaine Patch 5% Effectively Treats All Neuropathic Pain Qualities: Results of a Randomized, Double-Blind, Vehicle-Controlled, 3-Week Efficacy Study With Use of the Neuropathic Pain Scale
B. Galer (2002)
10.1097/00002508-200309000-00004
Development of a Neuropathic Pain Questionnaire
S. J. Krause (2003)
Development and preliminary val - dation of a pain measure specific to neuropathic pain : the europathic pain scale
BS Galer (1997)
10.1213/01.ANE.0000062826.70846.8D
Defining Neuropathic Pain
M. Backonja (2003)
10.1016/j.pain.2003.12.024
Development and validation of the Neuropathic Pain Symptom Inventory
D. Bouhassira (2004)
Gabapentin in neuropathic
MG Serpell
following WHO guidelines
SJ Krause
10.1016/S0304-3959(03)00160-X
Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy
C Peter N Watson (2003)
10.1213/01.ANE.0000081724.18956.D9
Neuropathic pain: a crisis of definition?
G. Bennett (2003)
10.1136/aim.20.4.207-a
Bonica's Management of Pain
J. D. Loeser (2001)
Scale : the Leeds assessment of europathic symptoms and signs
D Bouhassira (2001)
10.1001/JAMA.280.21.1837
Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.
M. Rowbotham (1998)
10.1136/bmj.324.7347.1183
Increasing response rates to postal questionnaires: systematic review
P. Edwards (2002)
syndromes : randomized , double blind , placebo - controlled trial
DL Streiner (2002)
10.1136/BMJ.325.7361.444
Increasing response rates to postal questionnaires
C. Iglesias (2002)
10.1016/S0304-3959(02)00255-5
Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial
M. Serpell (2002)
Pain clinic patients in northern Britain
H. Davies (1991)
10.1053/SARH.2003.50017
Use of the leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia.
M. Martínez-Lavín (2003)
Health Measurement Scales: A practical guide to thier development and use
D. Streiner (1989)
10.1212/WNL.48.2.332
Development and preliminary validation of a pain measure specific to neuropathic pain
B. Galer (1997)
10.1093/OXFORDJOURNALS.BMB.A072498
Neurogenic pain syndromes and their management.
D. Bowsher (1991)
10.1016/S0304-3959(01)00422-5
Clarifying the definition of neuropathic pain
M. Max (2002)
10.1016/S0304-3959(00)00482-6
The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs
M. Bennett (2001)
Global use of the Brief Pain Inven
HT Davies (1994)
10.1016/S0304-3959(02)00115-X
Need for differential assessment tools of neuropathic pain and the deficits of LANSS pain scale
M. Backonja (2002)
10.1258/JRSM.96.8.379
Identifying neuropathic pain in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic Symptoms and Signs Scale.
J. Potter (2003)
10.1016/S0304-3959(98)00138-9
Assessment and treatment of neuropathic cancer pain following WHO guidelines
S. Grond (1999)



This paper is referenced by
10.1016/j.pain.2013.11.013
Neuropathic pain in the general population: A systematic review of epidemiological studies
O. Hecke (2014)
10.1310/BMQ9-WVPA-JU7U-JPN0
Assessment of Pain After SCI in Clinical Trials
T. Bryce (2006)
Endra posisjon på skulderbladet kan gje endra svar på isometrisk test ved epicondyalgi
T. Bryn (2012)
10.2174/1874325001307010099
The Relationship Between Neuropathic Pain, and the Function of the Upper Limbs Based on Clinical Severity According to Electrophysiological Studies in Patients with Carpal Tunnel Syndrome
M. Sonohata (2013)
10.1097/NNR.0000000000000407
Transition From Acute to Chronic Pain in Lower Extremity Fracture Patients
Mari Griffioen (2020)
10.1177/1352458514544538
‘It feels like someone is hammering my feet’: Understanding pain and its management from the perspective of people with multiple sclerosis
A. M. Harrison (2015)
10.1016/j.jpain.2015.07.002
Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale.
T. Mendoza (2015)
10.1097/ACO.0000000000000216
Emerging targets in treating pain
D. S. Chang (2015)
10.1080/09593985.2020.1843211
Ultrasound-guided percutaneous electrical stimulation for a patient with cubital tunnel syndrome: a case report with a one-year follow-up.
C. Fernández-de-las-Peñas (2020)
10.1016/j.spinee.2017.10.071
Prognosis of sciatica and back-related leg pain in primary care: the ATLAS cohort
K. Konstantinou (2018)
Filipino version : Transcultural adaptation and validation in two widely spoken regional languages ( Tagalog and Cebuano ) 1
M. F. S. Gomez (2019)
10.1002/ejp.977
The prevalence and impact of chronic neuropathic pain on daily and social life: A nationwide study in a Japanese population
S. Inoue (2017)
10.1002/j.1532-2149.2013.00350.x
Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the Spanish population
A. Hamdan (2014)
10.1007/s12306-019-00633-y
The comparison of efficacy of single intraarticular steroid injection versus the combination of genicular nerve block and intraarticular steroid injection in patients with knee osteoarthritis: a randomised study.
V. Yılmaz (2019)
10.1111/iej.13017
Development and preliminary evaluation of a new screening instrument for atypical odontalgia and persistent dentoalveolar pain disorder
J. Durham (2019)
Métodos de avaliação da eficácia dos tratamentos para a dor.
Guilherme A M Barros (2009)
Self-reported symptoms and neurosensory function after electrical accidents : a survey among Swedish male electricians
Lisa Rådman (2016)
10.24926/iip.v10i1.1628
A Practice Based Chronic Pain Management Registry (CPMR): Structure and Content of Proposed Patient and Patient/Provider Platforms
Paul C. Langley (2019)
10.21236/ada618874
Regional Anesthesia and Valproate Sodium for the Prevention of Chronic Post-Amputation Pain
T. Buchheit (2014)
Effect of stavudine-based antiretroviral therapy on the severity of polyneuropathy in HIV/AIDS patients: a preliminary report from Zaria, Northern Nigeria.
O. Obiako (2011)
10.1016/j.joca.2020.07.010
Does preoperative neuropathic-like pain and central sensitisation affect the post-operative outcome of knee joint replacement for osteoarthritis? A systematic review and meta analysis.
A. Wluka (2020)
10.1177/0961203310389097
The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice
M. Mosca (2011)
10.1016/j.apmr.2014.02.026
Derivation of a clinical decision guide in the diagnosis of cervical facet joint pain.
G. Schneider (2014)
10.2519/jospt.2015.5414
Diagnostic Accuracy of the Slump Test for Identifying Neuropathic Pain in the Lower Limb.
Lawrence M Urban (2015)
10.1111/papr.12018
Diagnosing Neuropathic Pain in Patients with Cancer: Comparative Analysis of Recommendations in National Guidelines from European Countries
Virginie Piano (2013)
10.1016/j.pain.2007.09.003
Epidemiology of neuropathic pain: Can we use the screening tools?
M. Bennett (2007)
10.1007/s10067-015-3070-3
HPV vaccination syndrome. A questionnaire-based study
M. Martínez-Lavín (2015)
10.1016/S1474-4422(12)70189-8
Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach
R. Baron (2012)
10.1097/j.pain.0000000000000728
Differential expression of systemic inflammatory mediators in amputees with chronic residual limb pain
Alexander G Chamessian (2017)
10.1684/pnv.2008.0127
[Neuropathic pain in the elderly].
G. Pickering (2008)
10.3109/15360288.2010.549550
Critical Summaries of Innovations in Palliative Care Pharmacotherapy
Amy P. Abernethy Edited by (2011)
10.1016/j.ctro.2018.08.002
A neuropathic pain component as a predictor of improvement in pain interference after radiotherapy for painful tumors: A secondary analysis of a prospective observational study
T. Saitô (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar